PTH (1-34), but not strontium ranelate counteract loss of trabecular thickness and bone strength in disuse osteopenic rats

Bone

Volumn 53, Issue 1, 2013, Pages 51-58

  Brüel, Annemarie ^a   Vegger, Jens Bay ^a   Raffalt, Anders Christer ^b   Andersen, Jens Enevold Thaulov ^b   Thomsen, Jesper Skovhus ^a  

^a AARHUS UNIVERSITY   (Denmark)

^b TECHNICAL UNIVERSITY OF DENMARK   (Denmark)

Author keywords

Histomorphometry; Immobilization; Mechanics; PTH; Rat; Strontium ranelate

Indexed keywords

ACID PHOSPHATASE TARTRATE RESISTANT ISOENZYME; ALKALINE PHOSPHATASE; PARATHYROID HORMONE[1-34]; STRONTIUM RANELATE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BIOMECHANICS; BONE ATROPHY; BONE MASS; BONE STRENGTH; CONTROLLED STUDY; CORTICAL BONE; DRUG BLOOD LEVEL; DRUG EFFICACY; FEMALE; FEMUR NECK; MICRO-COMPUTED TOMOGRAPHY; MUSCLE MASS; MUSCULOSKELETAL SYSTEM PARAMETERS; NONHUMAN; OSSIFICATION; OSTEOCLAST; OSTEOPENIA; PERIOSTEUM; RAT; TRABECULAR BONE; TRABECULAR THICKNESS;

ALKALINE PHOSPHATASE; ANIMALS; BIOMECHANICS; BODY WEIGHT; BONE AND BONES; BONE DISEASES, METABOLIC; FEMALE; ORGAN SIZE; ORGANOMETALLIC COMPOUNDS; PARATHYROID HORMONE; RATS; RATS, WISTAR; THIOPHENES; TOMOGRAPHY, X-RAY COMPUTED;

EID: 84871503533     PISSN: 87563282     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.bone.2012.11.037     Document Type: Article

References (39)

1. Vico L., Collet P., Guignandon A., Lafage-Proust M.H., Thomas T., Rehaillia M., et al. Effects of long-term microgravity exposure on cancellous and cortical weight-bearing bones of cosmonauts. Lancet 2000, 355:1607-1611.
2. Thomsen J.S., Morukov B.V., Vico L., Alexandre C., Saparin P.I., Gowin W. Cancellous bone structure of iliac crest biopsies following 370 days of head-down bed rest. Aviat Space Environ Med 2005, 76:915-922.
3. Shackelford L.C., LeBlanc A.D., Driscoll T.B., Evans H.J., Rianon N.J., Smith S.M., et al. Resistance exercise as a countermeasure to disuse-induced bone loss. J Appl Physiol 2004, 97:119-129.
4. Lelovas P.P., Xanthos T.T., Thoma S.E., Lyritis G.P., Dontas I.A. The laboratory rat as an animal model for osteoporosis research. Comp Med 2008, 58:424-430.
5. Jee W.S., Yao W. Overview: animal models of osteopenia and osteoporosis. J Musculoskelet Neuronal Interact 2001, 1:193-207.
6. Chappard D., Chennebault A., Moreau M., Legrand E., Audran M., Basle M.F. Texture analysis of X-ray radiographs is a more reliable descriptor of bone loss than mineral content in a rat model of localized disuse induced by the Clostridium botulinum toxin. Bone 2001, 28:72-79.
7. Thomsen J.S., Christensen L.L., Vegger J.B., Nyengaard J.R., Bruel A. Loss of bone strength is dependent on skeletal site in disuse osteoporosis in rats. Calcif Tissue Int 2012, 90:294-306.
8. Neer R.M., Arnaud C.D., Zanchetta J.R., Prince R., Gaich G.A., Reginster J.Y., et al. Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis. N Engl J Med 2001, 344:1434-1441.
9. Hock J.M., Gera I. Effects of continuous and intermittent administration and inhibition of resorption on the anabolic response of bone to parathyroid hormone. J Bone Miner Res 1992, 7:65-72.
10. Turner R.T., Evans G.L., Lotinun S., Lapke P.D., Iwaniec U.T., Morey-Holton E. Dose-response effects of intermittent PTH on cancellous bone in hindlimb unloaded rats. J Bone Miner Res 2007, 22:64-71.
11. Ma Y.F., Jee W.S., Ke H.Z., Lin B.Y., Liang X.G., Li M., et al. Human parathyroid hormone-(1-38) restores cancellous bone to the immobilized, osteopenic proximal tibial metaphysis in rats. J Bone Miner Res 1995, 10:496-505.
12. Meunier P.J., Roux C., Seeman E., Ortolani S., Badurski J.E., Spector T.D., et al. The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis. N Engl J Med 2004, 350:459-468.
13. Reginster J.Y., Felsenberg D., Boonen S., Diez-Perez A., Rizzoli R., Brandi M.L., et al. Effects of long-term strontium ranelate treatment on the risk of nonvertebral and vertebral fractures in postmenopausal osteoporosis: results of a five-year, randomized, placebo-controlled trial. Arthritis Rheum 2008, 58:1687-1695.
14. Reginster J.Y., Seeman E., De Vernejoul M.C., Adami S., Compston J., Phenekos C., et al. Strontium ranelate reduces the risk of nonvertebral fractures in postmenopausal women with osteoporosis: Treatment of Peripheral Osteoporosis (TROPOS) study. J Clin Endocrinol Metab 2005, 90:2816-2822.
15. Marie P.J. Strontium ranelate: a physiological approach for optimizing bone formation and resorption. Bone 2006, 38:S10-S14.
16. Ammann P., Shen V., Robin B., Mauras Y., Bonjour J.P., Rizzoli R. Strontium ranelate improves bone resistance by increasing bone mass and improving architecture in intact female rats. J Bone Miner Res 2004, 19:2012-2020.
17. Delannoy P., Bazot D., Marie P.J. Long-term treatment with strontium ranelate increases vertebral bone mass without deleterious effect in mice. Metabolism 2002, 51:906-911.
18. Hott M., Deloffre P., Tsouderos Y., Marie P.J. S12911-2 reduces bone loss induced by short-term immobilization in rats. Bone 2003, 33:115-123.
19. Sheng Z.F., Ma Y.L., Tong D., Fang D.Y., Liang Q.C., Liu L.H., et al. Strontium ranelate prevents bone loss in a rat model of localized muscle paralysis. Ann Biomed Eng 2012, 40:657-665.
20. Hock J.M., Gera I., Fonseca J., Raisz L.G. Human parathyroid hormone-(1-34) increases bone mass in ovariectomized and orchidectomized rats. Endocrinology 1988, 122:2899-2904.
21. Oxlund H., Andreassen T.T. Simvastatin treatment partially prevents ovariectomy-induced bone loss while increasing cortical bone formation. Bone 2004, 34:609-618.
22. Gundersen H.J., Jensen E.B. The efficiency of systematic sampling in stereology and its prediction. J Microsc 1987, 147:229-263.
23. Thomsen J.S., Laib A., Koller B., Prohaska S., Mosekilde L., Gowin W. Stereological measures of trabecular bone structure: comparison of 3D micro computed tomography with 2D histological sections in human proximal tibial bone biopsies. J Microsc 2005, 218:171-179.
24. Karsdal M.A., Henriksen K., Sorensen M.G., Gram J., Schaller S., Dziegiel M.H., et al. Acidification of the osteoclastic resorption compartment provides insight into the coupling of bone formation to bone resorption. Am J Pathol 2005, 166:467-476.
25. Neutzsky-Wulff A.V., Karsdal M.A., Henriksen K. Characterization of the bone phenotype in ClC-7-deficient mice. Calcif Tissue Int 2008, 83:425-437.
26. Oxlund H., Ejersted C., Andreassen T.T., Torring O., Nilsson M.H. Parathyroid hormone (1-34) and (1-84) stimulate cortical bone formation both from periosteum and endosteum. Calcif Tissue Int 1993, 53:394-399.
27. Mosekilde L., Sogaard C.H., Danielsen C.C., Torring O. The anabolic effects of human parathyroid hormone (hPTH) on rat vertebral body mass are also reflected in the quality of bone, assessed by biomechanical testing: a comparison study between hPTH-(1-34) and hPTH-(1-84). Endocrinology 1991, 129:421-428.
28. Dobnig H., Turner R.T. The effects of programmed administration of human parathyroid hormone fragment (1-34) on bone histomorphometry and serum chemistry in rats. Endocrinology 1997, 138:4607-4612.
29. Jilka R.L. Molecular and cellular mechanisms of the anabolic effect of intermittent PTH. Bone 2007, 40:1434-1446.
30. Ma Y.L., Zeng Q.Q., Porras L.L., Harvey A., Moore T.L., Shelbourn T.L., et al. Teriparatide [rhPTH (1-34)], but not strontium ranelate, demonstrated bone anabolic efficacy in mature, osteopenic, ovariectomized rats. Endocrinology 2011, 152:1767-1778.
31. Turner R.T., Evans G.L., Cavolina J.M., Halloran B., Morey-Holton E. Programmed administration of parathyroid hormone increases bone formation and reduces bone loss in hindlimb-unloaded ovariectomized rats. Endocrinology 1998, 139:4086-4091.
32. Andreassen T.T., Oxlund H. The influence of combined parathyroid hormone and growth hormone treatment on cortical bone in aged ovariectomized rats. J Bone Miner Res 2000, 15:2266-2275.
33. Ejersted C., Andreassen T.T., Hauge E.M., Melsen F., Oxlund H. Parathyroid hormone (1-34) increases vertebral bone mass, compressive strength, and quality in old rats. Bone 1995, 17:507-511.
34. Peng S., Liu X.S., Wang T., Li Z., Zhou G., Luk K.D., et al. In vivo anabolic effect of strontium on trabecular bone was associated with increased osteoblastogenesis of bone marrow stromal cells. J Orthop Res 2010, 28:1208-1214.
35. Fuchs R.K., Allen M.R., Condon K.W., Reinwald S., Miller L.M., McClenathan D., et al. Strontium ranelate does not stimulate bone formation in ovariectomized rats. Osteoporos Int 2008, 19:1331-1341.
36. Bain S.D., Jerome C., Shen V., Dupin-Roger I., Ammann P. Strontium ranelate improves bone strength in ovariectomized rat by positively influencing bone resistance determinants. Osteoporos Int 2009, 20:1417-1428.
37. Bruel A., Olsen J., Birkedal H., Risager M., Andreassen T.T., Raffalt A.C., et al. Strontium is incorporated into the fracture callus but does not influence the mechanical strength of healing rat fractures. Calcif Tissue Int 2011, 88:142-152.
38. Boivin G., Deloffre P., Perrat B., Panczer G., Boudeulle M., Mauras Y., et al. Strontium distribution and interactions with bone mineral in monkey iliac bone after strontium salt (S 12911) administration. J Bone Miner Res 1996, 11:1302-1311.
39. Warner S.E., Sanford D.A., Becker B.A., Bain S.D., Srinivasan S., Gross T.S. Botox induced muscle paralysis rapidly degrades bone. Bone 2006, 38:257-264.